由阿联酋牵头的研究证明,糖尿病装置在空间工作,为有糖尿病的宇航员旅行铺平了道路。 A UAE-led study proves diabetes devices work in space, paving the way for astronauts with diabetes to travel.

由阿联酋牵头在Axiom任务4期间进行的一项研究表明,连续葡萄糖监测器和胰岛素笔等糖尿病管理工具在空间可靠地运作,标志着使糖尿病宇航员能够旅行的一个重要步骤。 A UAE-led study during the Axiom Mission 4 has shown that diabetes management tools like continuous glucose monitors and insulin pens work reliably in space, marking a major step toward enabling astronauts with diabetes to travel. 在国际空间站上进行的 " 套装飞行器 " 实验证实了在微重力中有效实时血糖监测和胰岛素投送功能,其结果与地面精确度相符。 Conducted aboard the International Space Station, the Suite Ride experiment confirmed real-time blood sugar monitoring and insulin delivery function effectively in microgravity, with results matching Earth-based accuracy. 这些调查结果在宇航员舒班舒舒舒克拉参加的为期18天的飞行任务中得到证实,是首次在轨道上使用这些装置,并支持实现公平利用空间和改善地球远程保健的更广泛目标。 The findings, validated during an 18-day mission involving astronaut Shubhanshu Shukla, represent the first use of these devices in orbit and support broader goals of equitable space access and improved remote healthcare on Earth.